Pharma IP Rights In China: Avoiding The Antitrust Pitfalls

Law360, New York (April 29, 2013, 12:41 PM EDT) -- Antitrust authorities globally are grappling with competition claims in the pharmaceutical sector. Recognizing that inventive pharmaceutical companies are entitled to protect their valuable intellectual property rights, antitrust authorities or courts will consider intervention to protect competition or even assess the value of the IPR....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!